To design new antimicrobial peptides, we have focused on various proteins which are not essential for self-defense but carry important responsibilities for biosystems. Previously, we reported that highly efficient antimicrobial properties or antiviral properties are inherent in the nuclear translocation signals and binding sites on laminin receptors. Here we introduce microtubule binding sites on tau proteins as new components for antimicrobial peptides. Strong antimicrobial activities against Staphylococcus aureus and Escherichia coil were found in tandem sequences of the binding sites on tau proteins. Moreover, the binding sites obtained significantly strong antimicrobial activities against bacteria and fungi when combined with a nuclear localization signal (NLS) and/or a peptide derived from a binding site of a laminin receptor. The antimicrobial activities of some of the tau-derived peptides were not affected by salt, cations, or serum that simulate the natural environment present in blood. Tau proteins so far have only been known as one of the microtubule-associated proteins (MAPs) which are especially abundant in the central nervous system within the brain. Our finding demonstrates that the binding sites on tau proteins possess high potential for becoming components in antimicrobial peptides. Designs based on binding sites of various proteins could become a useful method in peptide antibiotic research.
INTRODUCTION
Many pathogenic microorganisms exist in nature and come in contact with our skin and trachea, but we still manage to remain healthy and avoid infection most of the time. This is due to our high quality immunity system, which is how human beings can maintain such an antibody response. Recently, one simple system of that innate immunity which plays an important role in the protection against pathogenic infections has been identified, and that is the secretion of antimicrobial peptides from cells.
Moths which are infected by bacteria produce antimicrobial peptides called cecropins to protect themselves from contracting many serious diseases (Steiner et al., 1981) .
Bees also produce antimicrobial peptides called melittins for the same reason (Steiner et al., 1981; Casteels et al., 1989) . Some peptides had been found in the secretions of amphibian skins more than thirty years ago but were considered a homolog of hormones or neurotransmitters. Antimicrobial peptides were commonly found in infected insects and for a long time were thought to have been a unique defense system in invertebrates. Antimicrobial peptides called defensins were reported in human neutrophils in the early 1980s (Selsted et al., 1985) . An antimicrobial peptide called magainin was isolated from the secretions of frog (Xenopus laevis) skin (Zasloff, 1987) . From the time of these early discoveries, antimicrobial peptides have been recognized as one of the important defense systems in vertebrates as well. An antimicrobial peptide, piscidins, was first isolated from the mast cells (also known as eosinophilic granule cells) of fish (hybrid striped bass; Morone saxatilis x M. chrysops) in 2001 (Sliphaduang and Noga, 2001) . Plectasin, an antimicrobial peptide belonging to the defensins family, is active against bacteria, fungi and viruses and was isolated from a fungus (a saprophytic ascomycete Pseudoplectania nigrella) in 2005 (Mygind et al., 2005 . This study identified fungi as a novel source of antimicrobial defensins and also suggested that the defensins of insects, molluscs and fungi arose from a common ancestral gene. More than a hundred different varieties of antimicrobial peptides have been identified in mammalian epithelial tissues over the past two decades. In addition, several hundred varieties of artificial antimicrobial peptides have also been developed based on the identified natural antimicrobial peptides. Antimicrobial peptides are an essential part of the innate immunity that evolved in most living organisms over the course of 2.6 billion years to combat harmful microbes (Zasloff, 2002) . At present, there are problems such as the appearance of new pathogenic bacteria and the reemergence of tubercular infection. Antibiotic abuses have contributed to the spread of drug-resistant bacteria and the death toll from antibiotic-resistant bacteria is on the rise. Under such social circumstances, there are expectations that antimicrobial peptides are expected to be the next generation of antibiotics and will become an increasing focus of research all over the world.
Conventional antimicrobial peptides have been researched by isolating natural antimicrobial peptides from organisms and/or developing them based on characteristics of natural antimicrobial peptides such as cationic properties or amphipathic a -helices, etc. Unlike these approaches, we have focused on various proteins which are not essential for self-defense but carry important responsibilities for biosystems and previously found that highly efficient antimicrobial properties or antiviral properties are inherent in the nuclear translocation signals and binding sites of laminin receptors across different species (Kobayashi et al., 2006a (Kobayashi et al., , 2006b Kobayashi and Yoshida, 2006; Kobayashi and Yoshida, 2007) . In this study, we will introduce binding sites on tau proteins as new components for antimicrobial peptides.
The results demonstrated that tau-derived peptides have the potential to be effective components for antimicrobial peptides. Tau proteins are one of the microtubule-associated proteins (MAPs) which mediate the regulation of the microtubule function, serve as structural components within cells, and are involved in mitosis, cytokinesis, and vesicular transport in cellular processes. Tau proteins are especially abundant in the central nervous system within the brain and bind microtubules (MTs) to promote tubulin polymerization and stabilize microtubule dynamics (Cleveland et al., 1977; Drechsel et al., 1992) . The etiology and pathogenesis of neurodegenerative diseases such as Alzheimer's disease and Pick's disease are known to be disorders resulting in the formation of filamentous deposits of abnormal tau proteins in the brain. Human tau proteins are coded by a single gene consisting of 16 exons on chromosome 17. Six tau isoforms (3R/ON, 3R/1N, 3R/2N, 4R/ON, 4R/1N, and 4R/2N) are generated by alternative mRNA splicing in exons 2, 3, and 10 and are distinguished by their number of repeat domains. The repeat domains contain either three or four imperfect 18-amino acid repeats separated by 13-or 14-amino acid long inter-repeats and are localized in the C-terminal half of the protein. The binding to MTs is a complex process mediated in part by a flexible array of weak MT binding sites that are distributed throughout the MT binding domain delineated by these repeats and their inter-repeat sequences. The positive charges of the binding domains are another reason they interact with the surface of negatively charged MTs. Interestingly, 4R-tau isoforms are more efficient at promoting MT assembly and show higher MT binding affinity than 3R-tau isoforms do. This is due to the unique sequence of the inter-repeats between the first and second MT binding repeats in 4R-tau. This inter-repeat sequence has more than twice the binding affinity of any individual MT binding repeat region (Lee et al., 2001; Goedert et al., 1990) . A proline-rich region of tau proteins, which are located in a more central location of the protein than the repeat domains are, is also thought to be important for MT interaction (Lee et al., 2001; Goedert et al., 1990) .
Investigation was done into whether peptides derived from the binding domains of tau proteins could be effective components for antimicrobial peptides. We particularly focused on the inter-repeat domains and proline-rich regions which are known to possess a Nutrient broth (NB) was the medium used . antifungal potential although it depends on the combination as with the antibacterial potential.
DISCUSSION
Examining the results, it was discovered that an antimicrobial function is inherent in the peptides based on the binding sites of tau proteins and the function does not disappear even with the existence of salt, MgCl2, CaCl2, or horse serum. Taupep+Taupep, NLS +TauPeP, and TauPeP+ LR demonstrated a particularly strong effect against S. aureus which is a grampositive bacterium. In addition, NLS +Taupep +LR demonstrated a strong effect against both S. aureus and E. coli, which is a gram-negative bacterium. Moreover NLS +TauPeP and NLS +TauPeP+LR demonstrated antifungal activity against C. albicans. An arrangement such as this could produce better antimicrobial function in tau-derived peptides. The outer membrane of gram-negative bacteria is negatively charged and more hydrophilic than the membrane of gram-positive bacteria, so the NLS +Taupep +LR peptide could obtain a strong interaction with the membrane of E. coli by combining it to the positively charged NLS. However, if too many positive charges exist in a peptide sequence, the peptide easily gets affected by salt, cations, and serum which are all elements included in blood and it loses a wide spectrum of antimicrobial function. When designing antibacterial peptides, it is necessary to consider the balance of positive charges and negative charges in addition to the individual function of the materials. From this point of view, various kinds of cation balances for antimicrobial peptides could be produced by combinating Tau and peptides derived from other proteins and signal peptides such as NLS. This way, the antimicrobial peptides would have the capability to maintain antimicrobial activity against various microbes.
A new design principle that focuses on the functional regions of a variety of proteins which do not exist solely for self-defense in nature can be established for peptide antibiotics. In designing antibiotics, it is important to consider how the antibiotic interacts with the microbial membrane. Binding domains of proteins are often structurally stable and composed of amphipathic helices, so it would be worth focusing on these binding domains in particular as components for antimicrobial peptides which can effectively interact with microbial membranes.
Our design concept for antimicrobial peptides takes the design principle of focusing on protein functional regions and adds the idea of "combination" to it. Because a large number of combinations can be produced by combining peptides based on the functional regions, it is possible to quickly screen much more effective peptide antibiotics against new resistant microbes. When components of A and B are used in design, the antimicrobial activities of the A+ B sequences are almost identical to that of the B+A sequences. In combination peptides, the antimicrobial effect does not change even if the order of components is changed, but the ways they interact with microbes might be subtly different. This suggests that the B+A sequences might be effective against microbes which have grown resistant to the A + B sequences. Another benefit of this idea is that the cation balances, which are important for antimicrobial peptides when interacting with negatively charged microbial membranes, could be controlled by combining different peptides. Each microbe has a different quantity of net charge on the membrane. For example, the membranes of gram-negative bacteria are more hydrophilic.than the membranes of gram-positive bacteria and are strongly reinforced by cations in a simulated environment of blood. Considering a peptide cation balance suitable for each microbial membrane is necessary to facilitate the microbe-specific interaction of antimicrobial peptides.
Our experiments demonstrate that Tau peptides possess high potential for becoming components in antimicrobial peptides. Moreover, this finding reinforces our hypothesis that combination designs based on binding sites of proteins could become a useful method in peptide antibiotic research.
